NDRG1 and glioma: As DHA is an approved drug which additionally suppresses TMZ–induced activation of phospho-NDRG1, a known mechanism of resistance, our data builds on previous results to warrant initiating clinical trials combining TMZ with DHA in the treatment of glioma patients.